27 October 2023 / A new publication in the science journal ‘Frontiers in Bioengineering and Biotechnology’ comprehensively reviews unintended genetic changes in plants caused by new genetic engineering processes (or new genomic techniques, NGT). The study shows that the risks associated with NGT plants are frequently underestimated.
Testbiotech filed legal cases against EU Commission decisions
18 October 2023 / The General Court of the European Union today rejected two lawsuits against import approvals awarded to Bayer (T-605/21-8 and T-606/21-8) for genetically engineered plants. Testbiotech filed two legal cases against decisions made by the EU Commission to issue market approvals for genetically engineered soybeans and maize. According to Testbiotech, the risks associated with these transgenic plants have not been assessed as required by law.
Public activity started against deregulation of new genetic engineering (New GE)
13 October 2023 / Currently, all organisms obtained from genetic engineering (New GE) processes in the EU have to undergo risk assessment before they can be released, cultivated or marketed as food. However, strong pressure from the biotech lobby has resulted in the EU Commission wanting to abandon this basic principle in relation to plants obtained from New GE (also called new genomic techniques, NGT). Testbiotech is warning of the possible negative consequences for health, the environment, nature and the livelihoods of future generations.
Additional focus of Testbiotech projects
21 September 2023 / The Testbiotech website provides new content in regard to technology assessment and the introduction of genetically engineered organisms into agriculture. Its main aim is to promote a better understanding of the systemic effects that genetic engineering can have on agriculture, breeding, health, the environment and nature.